Viewing Study NCT07418034


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-30 @ 2:39 AM
Study NCT ID: NCT07418034
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-18
First Post: 2026-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
Sponsor: University of Maryland, Baltimore
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Cancer View
None Head and Neck Squamous Cell Cancer View
None Head and Neck Squamous Cell Carcinoma View
None Oropharyngeal Carcinoma View
None Oropharyngeal Squamous Cell Carcinoma (OPSCC) View
None Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma View
None Oropharyngeal Squamous Cell Carcinoma View
None Oropharyngeal Squamous Cell Carcinoma (SCC) View
None Oropharyngeal Squamous Cell Carcinoma (OPSCCA) View
None Oropharyngeal Cancer View
None Oropharyngeal Squamous Cell Cancer View
None HPV Positive Oropharyngeal Squamous Cell Carcinoma View
None HPV (Human Papillomavirus)-Associated Carcinoma View
None HPV 16 Positive Oropharyngeal Tumors (OPC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Transoral Robotic Surgery (TORS) View
None Head and Neck Cancer View
None Oropharynx Cancer View
None HPV p16 Oropharynx Cancer View
None Proton Therapy View
None Photon Therapy View
None Radiation Therapy View
None ctDNA View
None P16 positive View